Drug Pipeline

RN1701 injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 1/2
1
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07506668 RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas Relapsed/Refractory B-cell Lymphoma Not Yet Recruiting
Phase 1
NCT07316920 A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell… Relapsed/Refractory B-cell Lymphoma Not Yet Recruiting
Early Phase 1
NCT07563543 RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas Relapsed/Refractory B-cell Lymphoma Not Yet Recruiting
Sponsors Running RN1701 injection Trials
YANRU WANG (1) Affiliated Hospital of Nantong University (1) The First Affiliated Hospital with Nanjing Medical University (1)
Get alerts when RN1701 injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free